NUWE logo

NUWELLIS INC

NUWENASDAQ
🏆 #5524 by market capEarnings Nov 10US Equity
$542.49▲ $16.49 (+3.04%)
Simulated price
🔔
Track NUWE
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 3.0%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$71,530
Small Cap
📈Revenue Growth (YoY)
-5.4%
Declining
📊Gross Margin
69.7%
High
💵FCF Margin
-139.7%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
60
Fair
No chart data available for NUWE.

Trading Snapshot

Day Range
$535.78 – $549.33
52-Week Range
$0.71 – $172.90
Volume
$5.26B
Avg Volume
$5.23B
Shares Outstanding
92,201
Next Earnings
Oct 29, 2026

Fundamentals Snapshot

Annual Revenue
$8M
Last Q Revenue
$2M
P/E Ratio
-0.0
P/S Ratio
0.0x
EPS (TTM)
$-61.35
Dividend Yield
0.00%
Dilution (1yr)
−52.1%

Why Investors Own NUWE

  • ✓High-growth profile — revenue up -1.8% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 64% gross margin and 6% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

NUWE logo

NUWELLIS INC

NUWE
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$8M▼ −5.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
62.0%▼ −7.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$11M▲ +1.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$11M▲ +12.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
46K▼ −52.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$757K▼ −$4M YoY
StockOtter · stockotter.space

About NUWELLIS INC

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
60/100

Analyst Price Target

ⓘ
Average Target
$653.63
▲ +20.5% Upside
High Target$706.07
Low Target$506.32
Based on 33 analysts

Latest News & Updates

🚀
Bloomberg·2h ago

NUWELLIS INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift NUWE price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
CNBC·1d ago

NUWELLIS INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.